Addition of trastuzumab emtansine (T-DM1) in a human epidermal growth factor receptor 2–overexpressed metastatic carcinoma of the gallbladder patient to enhance survival: A case study

Biliary tract cancers are clinically and genetically heterogeneous cancer type with a worst prognosis among gallbladder adenocarcinoma patients. Systemic therapeutic options for metastatic biliary tract cancers are fewer, and there are limited treatment choices for the patients who progress on first...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavingia, Viraj, Thummar, Vipulkumar, Mehta, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709179/
https://www.ncbi.nlm.nih.gov/pubmed/36467008
http://dx.doi.org/10.1177/2050313X221137447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709179/
https://www.ncbi.nlm.nih.gov/pubmed/36467008
http://dx.doi.org/10.1177/2050313X221137447

Ejemplares similares